Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Persistently low alkaline phosphatase (ALP) points toward hypophosphatasia (HPP), a rare genetic disorder, rather than osteoporosis, because osteoporosis typically shows normal or elevated ALP levels. This distinction matters enormously: standard osteoporosis treatments like bisphosphonates and denosumab can worsen HPP by further suppressing bone mineralization, while HPP has its own targeted enzyme replacement therapy (asfotase alfa). Adults with HPP often present with recurring metatarsal stress fractures, atypical femoral fractures, early tooth loss, chronic bone pain, and elevated vitamin B6 levels alongside low ALP. Because low ALP can also stem from other causes such as malnutrition, hypothyroidism, celiac disease, or certain medications, confirming HPP requires repeat ALP testing, biomarker analysis, and ALPL gene testing. There are several important factors to consider before assuming a diagnosis or starting treatment, so review the complete details below.
If you are aware of your own bone health markers or are experiencing unexplained fractures, bone pain, or dental issues, understanding the difference between these conditions could change your treatment path entirely. A free, instant, online symptom check can help you organize your symptoms, identify patterns worth discussing with your doctor, and determine whether your presentation warrants further investigation into rare metabolic bone disease rather than routine osteoporosis management.
Last reviewed for medical accuracy: 08/18/2026
Alkaline phosphatase (ALP) is an enzyme involved in bone mineralization. In adult bone disorders, ALP levels help distinguish between conditions that weaken bones. While osteoporosis is common and often comes with normal or elevated ALP, significantly low ALP should prompt evaluation for hypophosphatasia (HPP), a rare inherited disorder. Early recognition of low ALP can prevent delayed diagnosis and improve outcomes.
Keyword: Low alkaline phosphatase in adult bone disorders
| Feature | Osteoporosis | Hypophosphatasia (HPP) |
|---|---|---|
| ALP Level | Normal to mildly elevated | Low or inappropriately normal |
| Primary Issue | Bone mass loss | Defective bone mineralization |
| Genetic Basis | Multifactorial (age, hormones) | Mutations in ALPL gene |
| Bone Density | Decreased | Variable; can be normal or low |
| Fracture Pattern | Vertebral, hip, wrist fractures | Stress fractures, pseudofractures |
| Other Lab Findings | Normal calcium, phosphate | Elevated substrates (e.g., phosphoethanolamine) |
Enzyme Deficiency
HPP is caused by mutations in the ALPL gene leading to deficient tissue-nonspecific alkaline phosphatase. Without enough ALP:
Unique Laboratory Pattern
Clinical Presentation
Adults with HPP may have:
Treatment Implications
If you or your doctor notice low ALP on routine blood work, consider the following:
Repeat Testing
Evaluate Substrates
Genetic Counseling and Testing
Specialist Referral
Symptom Assessment
If you’ve discovered low ALP on your lab results or are experiencing unexplained fractures or bone pain, it’s important to confirm the cause rather than assume osteoporosis. For a quick overview of potential symptoms, you might try a free, online symptom check, using the doctor approved Ubie Symptom Checker before your appointment.
Always speak to a doctor about any serious or life-threatening concerns. Early evaluation and treatment planning can make a significant difference in bone health and overall well-being.
(References)
* Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Lewiecki EM. Osteoporosis: Clinical Evaluation. 2000. PMID: 25905277.
* Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Marini JC, Dang Do AN. Osteogenesis Imperfecta. 2000. PMID: 25905334.
* Tsiantouli E, Biver E, Chevalley T, Petrovic R, Hannouche D, Ferrari S. Prevalence of Low Serum Alkaline Phosphatase and Hypophosphatasia in Adult Patients with Atypical Femur Fractures. Calcif Tissue Int. 2022 Jun;110(6):703-711. doi: 10.1007/s00223-022-00949-1. Epub 2022 Feb 28. PMID: 35229197; PMCID: PMC9108106.
* Ng E, Ashkar C, Seeman E, Schneider HG, Nguyen H, Ebeling PR, Sztal-Mazer S. A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients. Osteoporos Int. 2023 Feb;34(2):327-337. doi: 10.1007/s00198-022-06597-3. Epub 2022 Nov 24. PMID: 36434431.
* Schini M, Vilaca T, Gossiel F, Salam S, Eastell R. Bone Turnover Markers: Basic Biology to Clinical Applications. Endocr Rev. 2023 May 8;44(3):417-473. doi: 10.1210/endrev/bnac031. PMID: 36510335; PMCID: PMC10166271.
* Reis FS, Lazaretti-Castro M. Hypophosphatasia: from birth to adulthood. Arch Endocrinol Metab. 2023 May 25;67(5):e000626. doi: 10.20945/2359-3997000000626. PMID: 37249457; PMCID: PMC10665056.
* Whyte MP, McAlister WH, Mack KE, Mumm S, Madson KL. Pediatric hypophosphatasia: avoid diagnosis missteps! J Bone Miner Res. 2024 Jul 23;39(6):655-660. doi: 10.1093/jbmr/zjae098. PMID: 38905292.
* Gill AS, Sharma P, Nassar M, Marte E. Hypophosphatasia: A case report. World J Clin Cases. 2025 Jul 26;13(21):103642. doi: 10.12998/wjcc.v13.i21.103642. PMID: 40726933; PMCID: PMC12068182.
* Susin C, Stadler AF, Haas A, Albandar JM. Periodontal Manifestations of Systemic Diseases. J Periodontal Res. 2025 Sep 16. doi: 10.1111/jre.70034. Epub 2025 Sep 16. PMID: 40956006.
* Valdez Navarro E, Wong EM, Tile L, Cheung AM. The Clinical Spectrum of Hypophosphatasia in Older Adults. Clin Case Rep. 2025 Nov;13(11):e70920. doi: 10.1002/ccr3.70920. Epub 2025 Oct 30. PMID: 41179594; PMCID: PMC12575442.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.